학술논문
RBD-specific polyclonal F(ab´)2 fragments of equine antibodies in patients with moderate to severe COVID-19 disease: A randomized, multicenter, double-blind, placebo-controlled, adaptive phase 2/3 clinical trial
Document Type
Article
Author
Lopardo, G.; Barcelona, L.; Belloso, W.H.; Nannini, E.; Zylberman, V.; Lloret, S.P.; Goldbaum, F.; Colonna, M.; Sanguineti, S.; Muñoz, L.; Spatz, L.; Dobarro, M.; Lebersztein, G.; Farina, J.; Vidiella, G.; Bertetti, A.; Crudo, F.; Alzogaray, M.F.; Teijeiro, R.; Lambert, S.; Scublinsky, D.; Iacono, M.; Stanek, V.; Solari, R.; Cruz, P.; Casas, M.M.; Abusamra, L.; Luciardi, H.L.; Cremona, A.; Caruso, D.; de Miguel, B.; Millán, S.; Kilstein, Y.; Pereiro, A.; Sued, O.; Cahn, P.
Source
In: EClinicalMedicine . (EClinicalMedicine, April 2021, 34)
Subject
Language
English
ISSN
25895370